• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广泛期小细胞肺癌化疗后相关治疗的急性髓系白血病

Therapy-related acute myeloid leukemia after chemotherapy in extensive disease-small cell lung cancer.

作者信息

Ueda Naoko, Fujita Kohei, Okuno Yoshiaki, Nakatani Koichi, Mio Tadashi

机构信息

Division of Respiratory Medicine, Center for Respiratory Diseases National Hospital Organization Kyoto Medical Center Kyoto Japan.

Department of Nephrology National Hospital Organization Kyoto Medical Center Kyoto Japan.

出版信息

Clin Case Rep. 2018 Nov 19;7(1):100-103. doi: 10.1002/ccr3.1931. eCollection 2019 Jan.

DOI:10.1002/ccr3.1931
PMID:30656018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6332741/
Abstract

We experienced therapy-related acute myeloid leukemia (t-AML) in a patient with extensive disease-small cell lung cancer (ED-SCLC). This case is rare and has educational message because ED-SCLC has a poor prognosis and often cannot survive until developing therapy related hematological malignancy. Furthermore this case had unique chromosomal abnormalities. With recent advances in chemotherapy and radiotherapy, the prognosis of lung cancer has improved, while t-AML has been increasing in frequency.

摘要

我们在一名患有广泛期疾病——小细胞肺癌(ED-SCLC)的患者中遇到了治疗相关的急性髓系白血病(t-AML)。该病例较为罕见且具有教育意义,因为ED-SCLC预后较差,通常在发展为治疗相关血液系统恶性肿瘤之前就无法存活。此外,该病例存在独特的染色体异常。随着化疗和放疗的最新进展,肺癌的预后有所改善,而t-AML的发生率却在增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b93/6332741/ec366585bbd5/CCR3-7-100-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b93/6332741/c86adf17c62f/CCR3-7-100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b93/6332741/23b5c9e6c66a/CCR3-7-100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b93/6332741/ec366585bbd5/CCR3-7-100-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b93/6332741/c86adf17c62f/CCR3-7-100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b93/6332741/23b5c9e6c66a/CCR3-7-100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b93/6332741/ec366585bbd5/CCR3-7-100-g003.jpg

相似文献

1
Therapy-related acute myeloid leukemia after chemotherapy in extensive disease-small cell lung cancer.广泛期小细胞肺癌化疗后相关治疗的急性髓系白血病
Clin Case Rep. 2018 Nov 19;7(1):100-103. doi: 10.1002/ccr3.1931. eCollection 2019 Jan.
2
Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?治疗相关急性髓系白血病中16号染色体倒位及CBFB和MYH11基因的罕见重排:与DNA拓扑异构酶II抑制剂相关的罕见事件?
J Clin Oncol. 1998 May;16(5):1890-6. doi: 10.1200/JCO.1998.16.5.1890.
3
Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.治疗相关的急性髓系白血病肺癌幸存者的临床病理特征、风险和生存。
BMC Cancer. 2020 Nov 10;20(1):1081. doi: 10.1186/s12885-020-07603-9.
4
Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.100例小细胞肺癌患者使用标准剂量和高剂量依托泊苷、异环磷酰胺、卡铂及表柔比星的研究:一项成熟的随访报告
Ann Oncol. 1999 May;10(5):561-7. doi: 10.1023/a:1026453922931.
5
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.鬼臼毒素治疗后相关的急性髓系白血病:风险评估
Med Pediatr Oncol. 1994;23(2):86-98. doi: 10.1002/mpo.2950230205.
6
The incidence of secondary leukemias.继发性白血病的发病率。
Haematologica. 1999 Oct;84(10):937-45.
7
THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.一名接受化疗治疗皮肤弥漫性大B细胞淋巴瘤的患者发生的治疗相关T/髓系混合表型急性白血病。
J La State Med Soc. 2016 Jan-Feb;168(1):16-20. Epub 2016 Feb 15.
8
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.对100例连续的局限性和广泛性小细胞肺癌患者采用依托泊苷、异环磷酰胺、顺铂和表柔比星进行剂量密集治疗(VIP-E方案)。
Ann Oncol. 1997 Jan;8(1):49-56. doi: 10.1023/a:1008232329498.
9
Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report.自体造血干细胞移植治疗急性髓系白血病后继发慢性髓系白血病 2 例报告
Curr Med Res Opin. 2020 Nov;36(11):1807-1812. doi: 10.1080/03007995.2020.1808452. Epub 2020 Sep 29.
10
High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.大剂量异环磷酰胺、卡铂和依托泊苷联合自体外周血祖细胞移植治疗小细胞肺癌。
Anticancer Res. 1999 Jan-Feb;19(1B):693-8.

本文引用的文献

1
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer.随机 III 期临床试验:伊立替康联合顺铂对比依托泊苷联合顺铂治疗初治广泛期小细胞肺癌的韩国患者。
Cancer Res Treat. 2019 Jan;51(1):119-127. doi: 10.4143/crt.2018.019. Epub 2018 Mar 12.
2
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.美国成年人 1975-2008 年癌症化疗后治疗相关性急性髓系白血病的风险演变。
Blood. 2013 Apr 11;121(15):2996-3004. doi: 10.1182/blood-2012-08-448068. Epub 2013 Feb 14.
3
Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapy.
机组人员及接受放射治疗者的骨髓增生异常综合征和急性髓系白血病的细胞遗传学
Lancet. 2000;356(9248):2158. doi: 10.1016/s0140-6736(00)03501-7.
4
Treatment-related leukaemia--a clinical and scientific challenge.与治疗相关的白血病——一项临床与科学挑战。
Cancer Treat Rev. 2000 Oct;26(5):377-91. doi: 10.1053/ctrv.2000.0186.
5
Topoisomerase II inhibitor-related acute myeloid leukaemia.拓扑异构酶II抑制剂相关的急性髓系白血病
Br J Haematol. 2000 Apr;109(1):13-23. doi: 10.1046/j.1365-2141.2000.01843.x.
6
The incidence of secondary leukemias.继发性白血病的发病率。
Haematologica. 1999 Oct;84(10):937-45.
7
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.在接受晚期生殖细胞肿瘤治疗的患者中,高累积剂量依托泊苷后发生的继发性白血病。
J Clin Oncol. 1998 Oct;16(10):3386-91. doi: 10.1200/JCO.1998.16.10.3386.
8
Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.治疗相关白血病和骨髓增生异常综合征:临床、细胞遗传学及预后特征
J Clin Oncol. 1986 Dec;4(12):1748-57. doi: 10.1200/JCO.1986.4.12.1748.
9
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes.继发于拓扑异构酶II抑制剂的治疗相关急性髓系白血病:从床边到靶基因
Ann Oncol. 1992 Feb;3(2):107-11. doi: 10.1093/oxfordjournals.annonc.a058121.